OCT 08, 2015 9:38 AM PDT

Gut Microbiota Impact Who Develops Celiac Disease

WRITTEN BY: Kara Marker
Why do only 2-5% of individuals genetically susceptible to celiac disease actually end up developing this autoimmune disorder? Also, why has there been an increase in celiac disease prevalence in the past few decades?

Scientists from the Digestive Health Research Institute (DHRI) at McMaster University in Canada have possibly answered these questions in their recent American Journal of Pathology paper where they used humanized mice models to examine the role of gut microbiota in celiac disease pathology. 
Damaged enterocytes and villi
The U.S. National Library of Medicine reports that 30% of the general population have the gene variants causing susceptibility to developing celiac disease, but only approximately 3% of these people end up developing the disease. Until the results of the DHRI study were published today, the explanation for this differents in statistics did not extend past "environmental factors and changes in other genes." 

The humanized mice models in the DHRI study had varying amounts of gut microbiota. The mice genes were also manipulated to express human gene DQ8, making them susceptible to inflammatory responses in the presence of gluten. After treating the mice with gluten, scientists observed varying responses of mice according to the content of their gut microbiome. The looked for the following as a response to potential gluten allergy development:
  • intraepithelial lymphocytes (IELs), an early marker of celiac disease
  • cell death in cells lining GI tract (enterocytes)
  • anatomical changes in GI tract villi
  • anti-gliadin (gluten component) antibodies
  • pro-inflammatory T lymphocyte response to gliadin
All of these signs were highly present in mice with no gut microbiota ("germ-free"). 

"Our data argue that the recongized increase in celiac disease in the general population could be driven by perturbations in intestinal microbial ecologies," explains lead investigator Elena F. Verdu, MD, PhD. "Specific microbiota-based therapies may aid in the prevention or treatment of celiac disease."

The scientists were also able to prove that the response in germ-free mice was gluten-specific after a non-gluten protein, zein, did not impact IEL numbers. 

"These studies demonstrate that perturbation of early microbial colonization in life and induction of dysbiosis enhances the severity of gluten-induced responses in mice genetically predisposed to gluten sensitivity," Verdu adds. 

If disturbing the natural dynamic of our gut microbiota is enhancing gluten-induced responses in susceptible people, then what actions are to blame for this disturbance?

In a lengthy study in Genes & Nutrition in 2011, scientists examined the importance of gut microbial diversity as related to disease and human health. The results listed widespread antibiotic use as the major cause of increased disturbance in microbial diversity. Results included probiotic therapies as a potential counter to this disturbance. 

In addition to research on the gluten autoimmune response in patients with celiac disease, research also continues in the realm of a more vague, less understood non-celiac gluten sensitivity

To learn more about celiac disease pathology, check out the following video:



Source: Science Daily
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 12, 2020
Drug Discovery & Development
FEB 12, 2020
Does Traditional Chinese Medicine Work Against Coronavirus?
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 peo ...
FEB 19, 2020
Immunology
FEB 19, 2020
Testing the Immune Response to Ovarian Cancer Treatment
There is a new diagnostic test for the deadliest form of gynecological cancer – ovarian cancer. Better tests mean ...
MAR 23, 2020
Drug Discovery & Development
MAR 23, 2020
Top 5 Candidates for Coronavirus Vaccine Around the World
It’s easy to complain about the role of big pharma in medicine-making and the hassle of dealing with protective pa ...
APR 10, 2020
Drug Discovery & Development
APR 10, 2020
Cancer Therapy Drug Reverses Kidney Damage
According to a study published in the journal Science Translational Medicine, a therapeutic previously used for cancer t ...
MAY 05, 2020
Immunology
MAY 05, 2020
Winter the Llama: An Unlikely Hero in the Fight Against COVID-19
A new hero in the fight against COVID-19 has emerged: 4-year-old Winter, a llama that currently resides in the Belgian c ...
MAY 16, 2020
Neuroscience
MAY 16, 2020
Stem Cell Method (Parkinson's) Could Avoid Transplant Rejection
Researchers at McLean Hospital and Massachusetts General Hospital (MGH) have tested a stem cell treatment method that av ...
Loading Comments...